Trust Company of Vermont’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $93K | Sell |
|
|||||
|
2025
Q2 | $80.7K | Sell |
|
|||||
|
2025
Q1 | $214K | Sell |
|
|||||
|
2024
Q4 | $242K | Sell |
|
|||||
|
2024
Q3 | $302K | Buy |
|
|||||
|
2024
Q2 | $271K | Hold |
|
|||||
|
2024
Q1 | $277K | Buy |
|
|||||
|
2023
Q4 | $183K | Sell |
|
|||||
|
2023
Q3 | $227K | Sell |
|
|||||
|
2023
Q2 | $278K | Sell |
|
|||||
|
2023
Q1 | $295K | Sell |
|
|||||
|
2022
Q4 | $326K | Sell |
|
|||||
|
2022
Q3 | $386K | Sell |
|
|||||
|
2022
Q2 | $392K | Sell |
|
|||||
|
2022
Q1 | $545K | Hold |
|
|||||
|
2021
Q4 | $679K | Hold |
|
|||||
|
2021
Q3 | $762K | Sell |
|
|||||
|
2021
Q2 | $830K | Buy |
|
|||||
|
2021
Q1 | $830K | Sell |
|
|||||
|
2020
Q4 | $895K | Buy |
|
|||||
|
2020
Q3 | $689K | Buy |
|
|||||
|
2020
Q2 | $687K | Sell |
|
|||||
|
2020
Q1 | $855K | Sell |
|
|||||
|
2019
Q4 | $1.06M | Buy |
|
|||||
|
2019
Q3 | $829K | Buy |
|
|||||
|
2019
Q2 | $597K | Buy |
|
|||||
|
2019
Q1 | $539K | Buy |
|
|||||
|
2018
Q4 | $182K | Buy |
|
|||||
|
2018
Q3 | $218K | Buy |
|
|||||
|
2018
Q2 | $136K | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $17K | Buy |
|
|||||
|
2015
Q3 | $12K | Buy |
|